Anastasia Sioni
Athens, ESYE31 11522, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study group.
Journal: American journal of hematology
Published: December 18, 2022
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.
Journal: Hematological oncology
Published: December 23, 2020
Lymphoma Severity and Type Are Associated With Aortic FDG Uptake by 18F-FDG PET/CT Imaging.
Journal: JACC. CardioOncology
Published: January 14, 2020
Bortezomib retreatment for relapsed and refractory multiple myeloma in real-world clinical practice.
Bortezomib retreatment for relapsed and refractory multiple myeloma in real-world clinical practice.
Journal: Health science reports
Published: October 25, 2017
Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy.
Journal: Haematologica
Published: August 22, 2015
Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma.
Journal: Leukemia
Published: January 06, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026